Inventor
GUGLIELMOTTI ANGELO
IT25 patents
⚠️ This page may combine multiple inventors who share the name “GUGLIELMOTTI ANGELO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACRAF
9 patentsUS6534534B1Mar 18, 2003
Pharmaceutical composition active in reducing production of MCP-1 protein
ACRAF22 citations92
US7919518B2Apr 5, 2011
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
ACRAF6 citations73
US8017644B2Sep 13, 2011
2-arylindole derivatives as nPGES-1 inhibitors
ACRAF3 citations61
US7632849B2Dec 15, 2009
Indazolamides with analgesic activity
ACRAF5 citations60
US10005730B2Jun 26, 2018
3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
ACRAF0 citations51
US7662836B2Feb 16, 2010
Indazole having analgesic activity
ACRAF0 citations51
US7879836B2Feb 1, 2011
Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating appetite disorder
ACRAF0 citations50
US7638534B2Dec 29, 2009
Use of indazole derivatives for the treatment of neuropathic pain
ACRAF0 citations49
US6191158B1Feb 20, 2001
Pharmaceutical composition active in reducing production of MCP-1 protein
ACRAF1 citations48
GUGLIELMOTTI ANGELO
8 patentsUS8198310B2Jun 12, 2012
Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
GUGLIELMOTTI ANGELO15 citations90
US8835481B2Sep 16, 2014
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
GUGLIELMOTTI ANGELO13 citations83
US8461194B2Jun 11, 2013
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
GUGLIELMOTTI ANGELO6 citations83
US8569297B2Oct 29, 2013
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
GUGLIELMOTTI ANGELO2 citations62
US8314099B2Nov 20, 2012
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
GUGLIELMOTTI ANGELO5 citations62
US8283348B2Oct 9, 2012
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
GUGLIELMOTTI ANGELO4 citations61
US8846745B2Sep 30, 2014
Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
GUGLIELMOTTI ANGELO0 citations50
US9492542B2Nov 15, 2016
Pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseases
GUGLIELMOTTI ANGELO0 citations45
ALISI MARIA ALESSANDRA
5 patentsUS8455519B2Jun 4, 2013
Drug active in neuropathic pain
ALISI MARIA ALESSANDRA6 citations72
US8415476B2Apr 9, 2013
Indazole having analgesic activity
ALISI MARIA ALESSANDRA2 citations61
US8637682B2Jan 28, 2014
3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
ALISI MARIA ALESSANDRA0 citations50
US8519139B2Aug 27, 2013
Indazolamides with analgesic activity
ALISI MARIA ALESSANDRA0 citations49
US8686147B2Apr 1, 2014
Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it
ALISI MARIA ALESSANDRA0 citations36
AZIENDE CHIM RIUN ANG FRANC A C R A F S P A
2 patentsUS9255073B2Feb 9, 2016
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
AZIENDE CHIM RIUN ANG FRANC A C R A F S P A0 citations47
US9249097B2Feb 2, 2016
3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
AZIENDE CHIM RIUN ANG FRANC A C R A F S P A0 citations45